Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Margarita Bofill
Changes in T-Cell Subsets in HIV–HCV-coinfected Patients During Pegylated Interferon-Α2a Plus Ribavirin Treatment
Antiviral Therapy
Infectious Diseases
Pharmacology
Related publications
Changes in Immune Activation in the T Cell Compartments of HIV HCV Coinfected Patients During PEG IFN RBV Treatment
Retrovirology
Virology
Infectious Diseases
Decrease in Regulatory T-Cell Function in Chronic Hepatitis C Patients Receiving Pegylated-Interferon Plus Ribavirin
International Journal of Infectious Diseases
Medicine
Infectious Diseases
Microbiology
Dermatological Manifestations of Pegylated Interferon Alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
Afro-Egyptian Journal of Infectious and Endemic Diseases
IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin
Journal of Medical Virology
Virology
Infectious Diseases
Efficacy of 60 Weeks Treatment of Pegylated Interferon Plus Ribavirin in Patients Whose HCV RNA Tuned Negative by Real-Time PCR Assay at 12 Weeks
Acta Hepatologica Japonica
Hepatology
Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia
Current Therapeutic Research
Pharmacology
Trend of Estimated Glomerular Filtration Rate During Ombistasvir/Paritaprevir/Ritonavir Plus Dasabuvir ± Ribavirin in HIV/HCV Co-Infected Patients
PLoS ONE
Multidisciplinary
Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts
Journal of Acquired Immune Deficiency Syndromes
Infectious Diseases
Pharmacology
Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers
HIV Clinical Trials
